Skip Navigation



ToxSci Advance Access published online on September 29, 2004

Toxicological Sciences, doi:10.1093/toxsci/kfh296
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
82/2/451    most recent
kfh296v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lee, G.-S.
Right arrow Articles by Jeung, E.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, G.-S.
Right arrow Articles by Jeung, E.-B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 17, 2004
Accepted September 7, 2004

Endocrine Toxicology

Effect of Genistein as a Selective Estrogen Receptor Beta Agonist on the Expression of Calbindin-D9k in the Uterus of Immature Rats

Geun-Shik Lee 1, Kyung-Chul Choi 2, Hoe-Jin Kim 1, and Eui-Bae Jeung 1*

1 Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, 361-763 Republic of Korea
2 Department of Obstetrics and Gynecology, British Columbia Children's and Women's Hospital, British Columbia Research Institute for Children's and Women's Health, University of British Columbia, Vancouver, BC, V6H 3V5 Canada

* To whom correspondence should be addressed. E-mail: ebjeung{at}chungbuk.ac.kr.


   Abstract

Genistein, a phytoestrogen possessing a high affinity for estrogen receptor {beta} (ER{beta}), is of increasing interest because of its possible influence on the physiology of mammalian reproductive tracts. Although estrogen has been demonstrated to regulate Calbindin-D9k (CaBP-9k) in the rat uterus as with other calcium binding proteins, the role of ER{beta} on the modulation of CaBP-9k remains to be elucidated. To elucidate the effect of genistein as a selective ER{beta} agonist on uterine expression of CaBP-9k mRNA and protein, immature female rats were injected with genistein daily for 3 consecutive days in a dose-dependent (0.4, 4, and 40 mg/kg/day) and time-dependent (40 mg/kg/day; 3, 6, 12, 24, 48, and 72 h) manner. Then, the expression of CaBP-9k mRNA and protein was analyzed by Northern hybridization and Western blot, respectively, in the absence or presence of ICI 182,780 (ICI), an estrogen antagonist. In addition, the protein levels of ER{alpha} and ER{beta} and mRNA level of progesterone receptor (PR) were further measured following genistein treatment to elucidate which of ERs is involved in CaBP-9k modulation. In a dose-dependent experiment, the highest dose of genistein (40 mg/kg/day) for 3 days significantly induced uterine CaBP-9k protein as 17beta-estradiol (E2) did. In addition, its maximal mRNA expression was observed at 3 and 6 h, and it returned to control level at 24 h in a time-dependent experiment. In parallel with its mRNA level, the protein level of CaBP-9k was significantly induced by genistein at 3 h and sustained up to 48 h. The pre-treatment with ICI, followed by genistein or E2, completely blocked genistein- and E2-induced CaBP-9k protein in the uterus of immature rats. Interestingly, genistein was demonstrated to induce ER{alpha} protein, but not ER{beta} and PR mRNA, an E2-responsive gene, in this tissue. These results imply that genistein, an ER{beta} ligand, may regulate CaBP-9k gene through ER{alpha} pathway. Taken together, the present study demonstrated that genistein enhanced CaBP-9k gene via ER{alpha} in the uterus of immature rats, suggesting that ER{alpha} may be a key mediator in uterine CaBP-9k gene induction in immature rats.

Keywords: Calbindin-D9k; genistein; estrogen receptors; endocrine disruption.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
T. T. B. Vo and E.-B. Jeung
An Evaluation of Estrogenic Activity of Parabens Using Uterine Calbindin-D9k Gene in an Immature Rat Model
Toxicol. Sci., November 1, 2009; 112(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G.-S. Lee, K.-C. Choi, and E.-B. Jeung
K+-dependent Na+/Ca2+ exchanger 3 is involved in renal active calcium transport and is differentially expressed in the mouse kidney
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F371 - F379.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K.L. Greathouse, J.D. Cook, K. Lin, B.J. Davis, T.D. Berry, T.G. Bredfeldt, and C.L. Walker
Identification of Uterine Leiomyoma Genes Developmentally Reprogrammed by Neonatal Exposure to Diethylstilbestrol
Reproductive Sciences, October 1, 2008; 15(8): 765 - 778.
[Abstract] [PDF]


Home page
Toxicol SciHome page
V. H. Dang, K.-C. Choi, and E.-B. Jeung
Tetrabromodiphenyl Ether (BDE 47) Evokes Estrogenicity and Calbindin-D9k Expression through an Estrogen Receptor-Mediated Pathway in the Uterus of Immature Rats
Toxicol. Sci., June 1, 2007; 97(2): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G.-S. Lee, H.-J. Kim, Y.-W. Jung, K.-C. Choi, and E.-B. Jeung
Estrogen Receptor {alpha} Pathway Is Involved in the Regulation of Calbindin-D9k in the Uterus of Immature Rats
Toxicol. Sci., April 1, 2005; 84(2): 270 - 277.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.